SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Knowledge Extraction Technologies
ADK.V 0.345-1.4%3:38 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Baywall12/31/2015 9:50:41 PM
   of 4
 
Diagnos is on Facebook: www.facebook.com/DiagnosInc/

This post provides some information about operations. The personnel in India have posted pictures to Facebook. It shows various screening camps throughout India done in November and early December. Novartis/Diagnos mobile eye screening vehicle is shown. Throughout the US, Diagnos held screening events in New York, Chicago and San Diego to name a few. Some were sponsored by Regeneron, a US based pharmaceutical.

The role pharmaceuticals will play is still unclear. For now they are referred to as sponsors. Each has their own eye medications like Eylea and Lucentis.

A goal may be to get national representation with public health institutions. Progress in Mexico is closest to achieving this, albeit it's still in the early stages.

The US market has received attention. But I have no idea how that is progressing.This will be a key market financially.

South America is next with Bayer as the sponsor. We have Bayer, Novartis, and in the US a leading pharmaceutical on board. The logistics of being in many locations, is something to think about and whether Diagnos can succeed.

There are examples of competitors on the technology side of retinal screening. But worldwide onsite application alongside major pharmaceutical companies, I believe Diagnos is the only company.

It's too early to say the stock will move up. Rumours and expectations is all I can take in for now. I rely on chart analysis for investing, but this has its own limitations. From the above, it's hoped that at least, a strong foundation has been identified.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext